Gene expression profiling in breast cancer challenges the existence of intermediate histological grade

por Sotiriou, C, Wirapati, P, Loi, S, Harris, A, Bergh, J, Smeds, J, Praz, V, Farmer, P, Haibe-Kains, B, Lallemand, F, Buyse, M, Piccart, M, Delorenzi, M
Publicado 2005

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

por Stintzing, S, Wirapati, P, Lenz, H -J, Neureiter, D, Fischer von Weikersthal, L, Decker, T, Kiani, A, Kaiser, F, Al-Batran, S, Heintges, T, Lerchenmüller, C, Kahl, C, Seipelt, G, Kullmann, F, Moehler, M, Scheithauer, W, Held, S, Modest, D P, Jung, A, Kirchner, T, Aderka, D, Tejpar, S, Heinemann, V
Publicado 2019